Companies governed by the Commercial Act, small and medium-sized enterprises, and non-profit organizations that conduct animal testing as part of national R&D projects are now legally classified as animal testing institutions under the Animal Protection Act Enforcement Decree, alongside the government-funded research institutes already covered under the prior framework. These newly covered institutions are required to establish and operate an animal ethics committee and to submit animal testing protocols for prior review, mirroring governance requirements already in place for public research institutions. Administrative fines of up to 5 million KRW apply where an institution conducts animal testing in a national R&D project without an operating ethics committee or without prior review. No data on the number of institutions newly covered, ethics committees established, or enforcement actions taken is available in current sourcing.

Anticipated Effects

If applied consistently, the amendment would extend ethics-committee-based review and record-keeping obligations from government-funded institutes to a wider population of institutions participating in national R&D projects that use animals, increasing the proportion of national R&D animal testing subject to prior ethical review. This is a conditional expectation based on the amendment’s mechanism design and is not yet documented as a realized outcome in available sourcing.

Significance Rationale

The amendment affects a functionally important subset of the research and testing system — companies, SMEs, and non-profits participating in national R&D projects that use animals — but its scope is limited to nationally designated R&D projects rather than the entirety of animal experimentation in South Korea, and no quantitative data on affected institutions, animals, or facilities is available in current sourcing, which supports Moderate significance.